N1-([1,1'-Biphenyl]-2-yl)-N2-benzyloxalamide, 97%, 25g

N-{5-bromoimidazo[1,2-a]pyridin-2-yl}cyclopropanecarboxamide, 97.0%, 5g

Ethyl 2-amino-5-isopropoxybenzoate, 95+%, 100mg

N-phenyltetradecanamide, 99%, 25g

methyl 3-methoxy-2-naphthoate, 98.0%, 250mg

1H-Benzotriazole-1-methanol>98.0%(T)25g

THIENO[2,3-B]PYRIDINE-5-CARBOXYLIC ACID, 95.0%, 1g

methyl({[3-(trifluoromethyl)pyridin-2-yl]methyl})amine dihydrochloride, 1g

Volumetric flasks class A Brown glass, 5 ml, 10/19, 2 Piece(s)

1,2-Bis(4-methoxyphenyl)-2-oxoethyl Cyclohexylcarbamate>98.0%(HPLC)(N)200mg

Potassium trifluoro(3-methoxy-3-oxopropyl)borate, 95.0%, 10g

(R)-2-((tert-Butoxycarbonyl)amino)-2-(4-isopropoxyphenyl)acetic acid, 95%, 250mg

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-aminobutanoic acid, 95.0%, 1g